BIOSAPIEN INC
Implantable, biodegradable, drug-eluting device for localized chemotherapy delivery to pancreatic tumors
- Sector
- Medtech
- Headquarters
- NEW YORK, NY
- Total capital
- $256K
- Federal grants
- $256K
- 1 award · 2021
- Rank in peer group#169 of 542
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 11 pending · first 2021
- Rank in peer group#47 of 542
Capital timeline
Latest events
- Federal grantNSF · Phase I · SBIR Phase I: A novel 3D printed biodegradable mesh delivering active pharmaceutical ingredients in a sustained and localized manner$256K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 542 peers
Line = medianMedtech · Device
- Federal grants#169 · top 31%
- Granted patents#47 · top 9%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 4 granted of 15- PendingBiovessels For Use In Tissue EngineeringUSPTOApplication 19297127
- PendingDrug-eluting Surgical Articles And Related MethodsUSPTOApplication 18926772
- GrantedBiovessels For Use In Tissue EngineeringUSPTOUS 12,409,250
Show all 15 patent records
- Biovessels For Use In Tissue EngineeringMay 14, 2026 · Application 19297127Pending
- Drug-eluting Surgical Articles And Related MethodsSep 11, 2025 · Application 18926772Pending
- Biovessels For Use In Tissue EngineeringSep 9, 2025 · US 12,409,250Granted
- Drug-eluting Surgical Articles And Methods Of Use ThereofJun 5, 2025 · Application 18944843Pending
- Drug-eluting Biomaterials And Related MethodsApr 30, 2024 · US 11,969,527Granted
- Biovessels For Use In Tissue EngineeringDec 14, 2021 · US 11,197,945Granted
- Drug-eluting Surgical Articles With A Plurality Of Geometric ElementsFeb 23, 2021 · US 10,926,005Granted
- Drug-eluting Surgical Articles And Related MethodsApplication PCTUS2019068056Pending
- Biovessels For Use In Tissue EngineeringApplication PCTUS2019051001Pending
- Drug-eluting Surgical Articles And Related MethodsApplication 62783430Pending
- Drug-eluting Surgical Articles And Related MethodsApplication 18605063Pending
- Biovessels For Use In Tissue EngineeringApplication 62731564Pending
- Drug-eluting Surgical Articles And Methods Of Use ThereofApplication PCTUS2023022089Pending
- Drug-eluting Surgical Articles And Methods Of Use ThereofApplication 63342531Pending
- Drug-eluting Surgical Articles And Methods Of Use ThereofApplication 63342012Pending
Related companies, and why
- BIOSAPIEN INC.Shares a founder: Khatija Ali
- CLEARSIGHT, LLCSimilar federal contract value in Medtech · null in contracts
- MNT SMARTSOLUTIONS LLCSimilar federal contract value in Medtech · null in contracts
- ZEALOUS RESEARCH LLCSimilar federal contract value in Medtech · null in contracts
- Vibhudutta AwasthiSimilar federal contract value in Medtech · null in contracts
- MEGANANO DIAGNOSTICS INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .